Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Adenosine triphosphate is a culprit in causing the devastating damage of spinal cord injury

ATP - adenosine triphosphate, the vital energy source that keeps our body’s cells alive, runs amok at the site of a spinal cord injury, pouring into the area around the wound and killing the cells that normally allow us to move, scientists report in the cover story of the August issue of Nature Medicine.

29 Jul 2004

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

The finding suggests that a similar therapy might eventually be able to slow the devastating course of Parkinson's disease in humans.

29 Jul 2004

Research collaboration to discover novel oral drugs for the treatment of viral infections

Sunesis Pharmaceuticals, Inc. and Merck & Co., Inc. have announced that they have entered into a multi-year research collaboration to discover novel oral drugs for the treatment of viral infections.

29 Jul 2004

75 percent of Americans support call for more stem cell research

Public backing for stem cell research is neither a Republican nor Democratic issue and, as such, should not be turned into a political football during the 2004 elections, according to Civil Society Institute (CSI) President Pam Solo.

27 Jul 2004

New plan of action aims to reduce prescription drug costs by more than 50 percent

The United States Department of Health and Human Services has announced a new plan of action and regulatory mechanisms to deliver greater benefits. These benefits aim to reduce prescription costs by more than 50 percent for the average senior without coverage.

26 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo

26 Jul 2004

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Doctors are reporting some success in treating one of the most troubling symptoms of dementias such as Alzheimer’s disease. A drug commonly used to treat schizophrenia and other psychotic disorders appears effective at reducing actions like screaming at or slapping caregivers – agitated behaviors that occur in as many as half of patients.

23 Jul 2004

First well-conducted studies of use of antipsychotics in people with Alzheimer’s

A member of a class of drugs that are widely prescribed for abnormal behavioral symptoms in Alzheimer’s – but not often studied in people with the degenerative brain disease – proved to be effective and well tolerated in treating agitation in people with severe Alzheimer’s

23 Jul 2004

Effects of Huntington's disease mutation more complex than originally thought

Competing theories about why brain cells die in Huntington's disease may not be competitors after all, according to a report published July 21, 2004, in the online edition of the Annals of Neurology.

22 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Difficulties in performing day to day tasks could indicate the presence of mild cognitive impairment

Mild Cognitive Impairment, forgetfulness without dementia being present, is a term described as a subtle decline in thinking abilities. A person with MCI, for example, may experience memory problems greater than normally expected with aging, but that person does not show other symptoms of dementia, such as impaired judgment or reasoning, according to the Alzheimer's Association.

21 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

21 Jul 2004

Mustard greens, cabbages, broccoli, cauliflower and brussels sprouts help to preserve cognitive abilities in ageing women

Harvard Medical School researchers have found that women who eat lots of mustard greens, cabbages, broccoli, cauliflower or brussels sprouts in middle age preserved more of their cognitive abilities as they entered their 70s.

20 Jul 2004

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

Study shows that in older age, myelin insulation breaks down, resulting in a decline in the speed and efficiency of our brain

UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.

12 Jul 2004

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Adenosine triphosphate is a culprit in causing the devastating damage of spinal cord injury

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Research collaboration to discover novel oral drugs for the treatment of viral infections

75 percent of Americans support call for more stem cell research

New plan of action aims to reduce prescription drug costs by more than 50 percent

Donepezil may have short-term benefit for mild cognitive impairment

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

First well-conducted studies of use of antipsychotics in people with Alzheimer’s

Effects of Huntington's disease mutation more complex than originally thought

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Difficulties in performing day to day tasks could indicate the presence of mild cognitive impairment

Donepezil may have short-term benefit for mild cognitive impairment

Mustard greens, cabbages, broccoli, cauliflower and brussels sprouts help to preserve cognitive abilities in ageing women

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

Statins may help prevent memory loss connected to dementia or Alzheimer’s disease

New JCAHO helps consumers to choose a hospital that best suits their needs

Drug slows the progression of mild cognitive impairment

Dementia often goes undiagnosed in primary care

Dietary niacin may protect against the development of Alzheimer's disease

Study shows that in older age, myelin insulation breaks down, resulting in a decline in the speed and efficiency of our brain

The Incredible Potential of Lipid Nanoparticles (LNPs)

Hasret Altan-Martin

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Immunology eBook

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

The Incredible Potential of Lipid Nanoparticles (LNPs)

Hasret Altan-Martin

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Immunology eBook

Newsletters you may be interested in